Safety and tolerability of the dual 5α-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia

Gerald L. Andriole, Roger Kirby

Research output: Contribution to journalArticlepeer-review

166 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and tolerability of the dual 5α-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences